Ross Clark Ross Clark

Could blood plasma be used to treat Covid-19?

Photo by BEN STANSALL/AFP via Getty Images

What are we to make of the decision by the US Food and Drug Administration (FDA) to grant emergency use authorisation for blood plasma treatment of Covid-19? Is this a medical breakthrough or a dangerous move forced on it by a desperate president who sees his electoral chances slipping away unless he somehow gets on top of the crisis over the next few weeks?

It goes without saying that the approval of drugs ought to be above partisan politics.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in